Expansion of a cell population expressing stem cell markers in parathyroid glands from patients with hyperparathyroidism

Annals of Surgery

Volumn 251, Issue 1, 2010, Pages 107-113

  Fang, Sandy H ^a   Guidroz, Julie A ^a   O'Malley, Yunxia ^a   Lal, Geeta ^a   Sugg, Sonia L ^a   Howe, James R ^a   Jensen, Chris S ^a   Weigel, Ronald J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; HERMES ANTIGEN; LYMPHOCYTE ANTIBODY;

ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; PARATHYROID GLAND; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECONDARY HYPERPARATHYROIDISM; STEM CELL EXPANSION; TISSUE SECTION; FLOW CYTOMETRY; IMMUNOLOGY; PATHOLOGY; STEM CELL;

ANTIGENS, CD24; ANTIGENS, CD44; FLOW CYTOMETRY; HUMANS; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; PARATHYROID GLANDS; STEM CELLS;

EID: 74049100443     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b5da28     Document Type: Article

References (23)

1. Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. NEngl J Med. 1980;302:189-193.
2. Melton LJ III. Epidemiology of primary hyperparathyroidism. J Bone Miner Res. 1991;6(suppl 2):S25-S30; discussion S1-S2.
3. Miller BS, Dimick J, Wainess R, et al. Age-and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg. 2008;32:795-799.
4. Arnold A, Shattuck TM, Mallya SM, et al. Molecular pathogenesis of primary hyperparathyroidism. J Bone Miner Res. 2002;17(suppl 2):N30-N36.
5. Arnold A, Brown MF, Urena P, et al. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest. 1995;95:2047-2053.
6. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-111.
7. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med. 2006;355:1253-1261.
8. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983-3988. (Pubitemid 36418143)
9. Ponti D, Zaffaroni N, Capelli C, et al. Breast cancer stem cells: an overview. Eur J Cancer. 2006;42:1219-1224.
10. Hurt EM, Kawasaki BT, Klarmann GJ, et al. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer. 2008;98:756-765.
11. Huang P, Wang CY, Gou SM, et al. Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma. World J Gastroenterol. 2008;14: 3903-3907.
12. Vermeulen L, Todaro M, de Sousa Mello F, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA. 2008;105:13427-13432.
13. Zou GM. Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver. J Cell Physiol. 2008;217:598-604.
14. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67:1030-1037. (Pubitemid 46270758)
15. Gunthert U. CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol. 1993;184:47-63.
16. Thorne RF, Legg JW, Isacke CM. The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events. J Cell Sci. 2004;117:373-380.
17. Lee CJ, Dosch J, Simeone DM. Pancreatic cancer stem cells. J Clin Oncol. 2008;26:2806-2812.
18. Alison MR, Islam S. Attributes of adult stem cells. J Pathol. 2009;217:144-160.
19. Buszczak M, Spradling AC. Searching chromatin for stem cell identity. Cell. 2006;125:233-236.
20. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8:755-768.
21. Cheng XY, O'Neill HC. Oncogenesis and cancer stem cells: current opinions and future directions. J Cell Mol Med. In press.
22. Seelentag WK, Komminoth P, Saremaslani P, et al. CD44 isoform expression in the diffuse neuroendocrine system. Part I: normal cells and hyperplasia. Histochem Cell Biol. 1996;106:543-550. (Pubitemid 26422759)
23. Komminoth P, Seelentag WK, Saremaslani P, et al. CD44 isoform expression in the diffuse neuroendocrine system. Part II: benign and malignant tumors. Histochem Cell Biol. 1996;106:551-562. (Pubitemid 26422760)